The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFFWD.L Regulatory News (FFWD)

  • There is currently no data for FFWD

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Disposal of Interest in Cryptologic Corp

8 Jan 2020 07:00

RNS Number : 0601Z
FastForward Innovations Limited
08 January 2020
 

FastForward Innovations Ltd / AIM: FFWD / Sector: Closed End Investments

8 January 2020

FastForward Innovations Ltd

("FastForward", "FFWD" or the "Company")

Disposal of Interest in Cryptologic for approximately C$1.5m

 

FastForward Innovations Ltd, the AIM listed closed ended investment fund with a focus on disruptive high growth technology and life sciences businesses, is pleased to announce that it has completed the sale of its entire holding of debentures in investee company Cryptologic Corp., formerly Vogogo Inc. ("Cryptologic").

 

Overview

·; Sale of the Company's total holding of 2,300,000 debentures in Cryptologic (CNSX: CRY) at an average price of C$0.66 per debenture (the "Sale")

·; Total realised cash proceeds from the Sale are C$1,514,476 (an equivalent of approximately £886,000 based on an indicative 0.585 exchange rate)

·; In addition, the Company has received coupon payments / accrued interest totalling C$257,075 (an equivalent of approximately £150,300 on an indicative 0.585 exchange rate) over the holding period

·; The purchase price of each debenture on investment in June 2018 was C$1.00, a total cost of C$2.3 million (£1.3 million)

·; As indicated in the results to 31 March 2019, FFWD carried the debentures at a significantly impaired valuation of C$863,000 (£494,000), following the poor performance of Cryptologic (attributed to the decline of the BitCoin price in late 2018 / early 2019 and a loss of attraction in the Cryptocurrency space generally). This impairment methodology was carried through the interim valuation provided in September 2019

·; Therefore, the Sale proceeds and coupon payments received since March 2019 represent a total gain of C$809,000 (94%) over the March 2019 NAV, but a total loss on investment of C$528,450 (23%) over the entire holding period, excluding foreign exchange movements

·; The Sale is in line with the Company's strategy to focus investments specifically in the life science, health and technology arenas

 

As per the announcements dated 6 August 2019, 12 August 2019 and 26 September 2019, Cryptologic, a Canadian listed company currently involved in cryptocurrency mining, is seeking to pivot into the Canadian Cannabis Industry by way of a proposed acquisition of assets from the Wayland Group and the sale of its Bitcoin mining business. The proposed resultant business of Cryptologic is not in line with FastForward's investment mandate and would have precluded the Company's continued involvement due to UK regulatory constraints. FastForward has therefore been looking at opportunities to realise its investment in Cryptologic in line with its evolved strategy to focus investments more specifically in the life science, health and technology arenas, and the sale of its entire holding of debentures in Cryptologic is reflective of this. The Company will deploy the proceeds of the sale in line with this strategy.

 

Ed McDermott, Director of FastForward, commented: "We have been looking for opportunities to dispose of our interest in Cryptologic since the announcement that it would be considering the acquisition of Wayland and I am therefore delighted to have completed the sale in a timely manner. Whilst we have made a loss over the holding period, given the difficult trading conditions with serious impacts on profitability due to considerable fluctuations in the BitCoin price, we are pleased to have exited in the position that we have."

 

This announcement contains inside information for the purposes of Article 7 of Regulation (EU) 596/2014.

* ENDS*

 

 

For further information on the Company please visit www.fstfwd.co or contact:

 

Ed McDermott

Lance de Jersey

FastForward Innovations Ltd

Email: info@fstfwd.co

 

James Biddle

Roland Cornish

Beaumont Cornish Limited

Nomad

 

Tel: +44 (0) 20 7628 3396

 

Jeremy Dickson

Optiva Securities Limited

Broker

 

Tel: +44 (0) 203 411 1881

 

Beth Melluish / Isabel de Salis

St Brides Partners Ltd

Financial PR

 

Tel: +44 (0)20 7236 1177

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DISEAXFXESAEEFA
Date   Source Headline
23rd Jul 20187:00 amRNSAgreement
19th Jul 201812:40 pmRNSFurther investment in Intensity Therapeutics Inc.
9th Jul 201811:17 amRNSIncreased holding in Fralis LLC (Leap Gaming)
6th Jul 20185:44 pmRNSResults for the year ended 31st March 2018
22nd Jun 20182:30 pmRNSInvestment in Vogogo Inc. Conv. Debenture Units
20th Jun 20186:20 pmRNSInvestee Company Update
19th Jun 20187:00 amRNSInvestment in Juvenescence Limited
12th Jun 20187:00 amRNSInvestee Company Update: Subscription into Fralis
11th Jun 20189:53 amRNSSale of Aphria Shares
16th May 20187:00 amRNSRegulatory Approval
23rd Mar 20183:35 pmRNSInvestee Company Update: Nuuvera Inc.
21st Mar 20181:28 pmRNSInvestee Company Update: Nuuvera
12th Mar 20181:00 pmRNSKey Investor Document
7th Mar 20182:34 pmRNSDirector/PDMR Shareholding
7th Mar 20187:00 amRNSProposed Director's Dealing
27th Feb 20183:43 pmRNSInvestee Company Update: Intensity Therapeutics
26th Feb 20184:01 pmRNSInvestee Company Update: Nuuvera
20th Feb 20183:26 pmRNSInvestee Company Update: Nuuvera
13th Feb 201812:22 pmRNSDirector Appointment
13th Feb 201812:05 pmRNSResult of AGM
12th Feb 20184:51 pmRNSTransaction in Own Shares
6th Feb 20189:37 amRNSCorrection of Notice of AGM
2nd Feb 20189:35 amRNSInvestee Company Update: Vemo
31st Jan 201811:04 amRNSTransaction in Own Shares
30th Jan 20185:00 pmRNSNotice of AGM
30th Jan 20184:20 pmRNSNotice of AGM
30th Jan 20188:35 amRNSHolding(s) in Company
29th Jan 20181:33 pmRNSInvestee Company Update: Nuuvera
23rd Jan 20182:43 pmRNSExtension of Share Buy-back Programme
23rd Jan 20181:19 pmRNSTransaction in Own Shares
18th Jan 20183:18 pmRNSInvestment Company Updates: Nuuvera
16th Jan 20183:36 pmRNSInvestee Company Update: Nuuvera
12th Jan 20183:43 pmRNSInvestee Company Update: Nuuvera
12th Jan 20182:23 pmRNSInvestee Company Update: Nuuvera
11th Jan 20188:00 amRNSInvestee Company Update: Nuuvera
8th Jan 20187:00 amRNSInvestee Company Update: Nuuvera
2nd Jan 201811:26 amRNSInvestee Company update: Nuuverra transaction
28th Dec 20173:29 pmRNSHalf-year Report
15th Dec 20179:23 amRNSCompany Secretary Change
15th Dec 20177:00 amRNSInvestee Company Update: Nuuvera
29th Nov 20174:14 pmRNSTransaction in Own Shares
29th Nov 20177:00 amRNSHolding(s) in Company
28th Nov 20174:06 pmRNSTransaction in Own Shares
23rd Nov 201710:12 amRNSHolding(s) in Company
20th Nov 201710:30 amRNSShare Buy-Back Programme
20th Nov 20179:56 amRNSMarket Update
3rd Nov 201712:00 pmRNSInvestee Company Update
9th Oct 20177:00 amRNSUpdate on Nuuverra Investment
18th Sep 20177:00 amRNSDisposal of interest in investee company
15th Aug 20177:00 amRNSInvestee Company Update: Schoold

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.